Planta Medica Letters 2015; 2(1): e15-e18
DOI: 10.1055/s-0035-1545936
Letter
Georg Thieme Verlag KG Stuttgart · New York

Neuroprotective Effect of Demethylsuberosin, a Proteasome Activator, against MPP+-induced Cell Death in Human Neuroblastoma SH-SY5Y Cells

Bo-Hyung Kim
1   Natural Products Research Institute, College of Pharmacy, Seoul National University, Seoul, Republic of Korea
,
Jaeyoung Kwon
2   Department of Biosystems and Biotechnology, Korea University, Seoul, Republic of Korea
,
Dongho Lee
2   Department of Biosystems and Biotechnology, Korea University, Seoul, Republic of Korea
,
Woongchon Mar
1   Natural Products Research Institute, College of Pharmacy, Seoul National University, Seoul, Republic of Korea
› Author Affiliations
Further Information

Publication History

received 21 December 2014
revised 13 March 2015

accepted 22 March 2015

Publication Date:
23 April 2015 (online)

Abstract

Demethylsuberosin isolated from the roots of Cudrania tricuspidata demonstrated a potent proteasome activator by enhancing all three chymotrypsin-like, trypsin-like, and caspase-like proteasome activities in a 20S proteasome activity assay. It also attenuated the 1-methyl-4-phenylpyridinium-induced dysfunction of the chymotrypsin-like and caspase-like activities of proteasome in SH-SY5Y cells with EC50 values of 0.76 µM and 0.82 µM, respectively. Additionally, demethylsuberosin protected neuronal cells against 1-methyl-4-phenylpyridinium-induced cell death with an EC50 value of 0.17 µM, while the EC50 value of betulinic acid was 4.29 µM. We are reporting that demethylsuberosin is a potent proteasome activator with a neuroprotective effect, suggesting a possible candidate for the protection or treatment of neurodegenerative diseases such as Parkinsonʼs disease.

Supporting Information

 
  • References

  • 1 Jeong CH, Choi GN, Kim JH, Kwak JH, Jeong HR, Kim DO, Heo HJ. Protective effects of aqueous extract from Cudrania tricuspidata on oxidative stress-induced neurotoxicity. Food Sci Biotechnol 2010; 19: 1113-1117
  • 2 Seo WG, Pae HO, Oh GS, Chai KY, Yun YG, Kwon TO, Chung HT. Inhibitory effect of ethyl acetate fraction from Cudrania tricuspidata on the expression of nitric oxide synthase gene in RAW 264.7 macrophages stimulated with interferon-gamma and lipopolysaccharide. Gen Pharmacol 2000; 35: 21-28
  • 3 Lee BW, Lee JH, Lee ST, Lee HS, Lee WS, Jeong TS, Park KH. Antioxidant and cytotoxic activities of xanthones from Cudrania tricuspidata . Bioorg Med Chem Lett 2005; 15: 5548-5552
  • 4 Kwon J, Hiep NT, Kim DW, Hwang BY, Lee HJ, Mar W, Lee D. Neuroprotective Xanthones from the Root Bark of Cudrania tricuspidata . J Nat Prod 2014; 77: 1893-1901
  • 5 Hiep NT, Kwon J, Kim DW, Hwang BY, Lee HJ, Mar W, Lee D. Isoflavones with neuroprotective activities from fruits of Cudrania tricuspidata . Phytochemistry 2015; 111: 141-148
  • 6 Trumble JT, Millar JG. Biological activity of marmesin and demethylsuberosin against a generalist herbivore, Spodoptera exigua (Lepidoptera: Noctuidae). J Agric Food Chem 1996; 44: 2859-2864
  • 7 Ma Y, Jung JY, Choi JH, Jeong WS, Song YS, Kang JS, Bi K, Kim MJ. Anti-inflammatory activities of coumarins isolated from Angelica gigas Nakai on LPS-stimulated RAW 264.7 cells. J Food Sci Nutr 2009; 14: 179-187
  • 8 Sin N, Kim KB, Elofsson M, Meng L, Auth H, Kwok BH, Crews CM. Total synthesis of the potent proteasome inhibitor epoxomicin: a useful tool for understanding proteasome biology. Bioorg Med Chem Lett 1999; 9: 2283-2288
  • 9 Kuhn DJ, Chen Q, Voorhees PM, Strader JS, Shenk KD, Sun CM, Demo SD, Bennett MK, van Leeuwen FW, Chanan-Khan AA, Orlowski RZ. Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma. Blood 2007; 110: 3281-3290
  • 10 Huang L, Ho P, Chen CH. Activation and inhibition of the proteasome by betulinic acid and its derivatives. FEBS Lett 2007; 581: 4955-4959
  • 11 McNaught KS, Olanow CW, Halliwell B, Isacson O, Jenner P. Failure of the ubiquitin-proteasome system in Parkinsonʼs disease. Nat Rev Neurosci 2001; 2: 589-594
  • 12 McNaught KS, Belizaire R, Isacson O, Jenner P, Olanow CW. Altered proteasomal function in sporadic Parkinsonʼs disease. Exp Neurol 2003; 179: 38-46
  • 13 Mizuno Y, Suzuki K, Sone N, Saitoh T. Inhibition of ATP synthesis by 1-methyl-4-phenylpyridinium ion (MPP+) in isolated mitochondria from mouse brains. Neurosci Lett 1987; 81: 204-208
  • 14 Lim KL. Ubiquitin-proteasome system dysfunction in Parkinsonʼs disease: current evidence and controversies. Expert Rev Proteomics 2007; 4: 769-781
  • 15 Jiang H, Hamada Y. Highly enantioselective synthesis of angelmarin. Org Biomol Chem 2009; 7: 4173-4176
  • 16 Jansen AH, Reits EA, Hol EM. The ubiquitin proteasome system in glia and its role in neurodegenerative diseases. Front Mol Neurosci 2014; 7: 73
  • 17 Ramsay RR, Salach JI, Singer TP. Uptake of the neurotoxin 1-methyl-4-phenylpyridine (MPP+) by mitochondria and its relation to the inhibition of the mitochondrial oxidation of NAD+-linked substrates by MPP+. Biochem Biophys Res Commun 1986; 134: 743-748
  • 18 Chiba K, Trevor AJ, Castagnoli jr. N. Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes. Biochem Biophys Res Commun 1985; 128: 1228-1232
  • 19 Lee DH, Kim CS, Lee YJ. Astaxanthin protects against MPTP/MPP+-induced mitochondrial dysfunction and ROS production in vivo and in vitro . Food Chem Toxicol 2011; 49: 271-280
  • 20 Sheng GQ, Zhang JR, Pu XP, Ma J, Li CL. Protective effect of verbascoside on 1-methyl-4-phenylpyridinium ion-induced neurotoxicity in PC12 cells. Eur J Pharmacol 2002; 451: 119-124
  • 21 Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 1987; 47: 936-942
  • 22 Lovborg H, Oberg F, Rickardson L, Gullbo J, Nygren P, Larsson R. Inhibition of proteasome activity, nuclear factor-KappaB translocation and cell survival by the antialcoholism drug disulfiram. Int J Cancer 2006; 118: 1577-1580